Literature DB >> 20561053

Neuronal growth-inhibitory factor (metallothionein-3): evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain.

Claire Howells1, Adrian K West, Roger S Chung.   

Abstract

Neuronal growth-inhibitory factor, later renamed metallothionein-3, is one of four members of the mammalian metallothionein family. Metallothioneins are a family of ubiquitous, low-molecular-weight, cysteine-rich proteins. Although neuronal growth-inhibitory factor shares metal-binding and reactive oxygen species scavenging properties with the other metallothioneins, it displays several distinct biological properties. In this review, we examine the recent developments regarding the function of neuronal growth-inhibitory factor within the brain, particularly in response to brain injury or during neurodegenerative disease progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561053     DOI: 10.1111/j.1742-4658.2010.07718.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  19 in total

Review 1.  Crosstalk of reactive oxygen species and NF-κB signaling.

Authors:  Michael J Morgan; Zheng-gang Liu
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 2.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

Review 3.  Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins.

Authors:  Adrian K West; Jacqueline Y K Leung; Roger S Chung
Journal:  J Biol Inorg Chem       Date:  2011-07-21       Impact factor: 3.358

4.  Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.

Authors:  Ryan P Lange; Allen Everett; Pratima Dulloor; Frederick K Korley; Chetan Bettegowda; Cherie Blair; Stuart A Grossman; Matthias Holdhoff
Journal:  Cancer Invest       Date:  2014-07-14       Impact factor: 2.176

5.  Assessment of the Therapeutic Potential of Metallothionein-II Application in Focal Cerebral Ischemia In Vitro and In Vivo.

Authors:  Abass Eidizadeh; Manuel Khajehalichalehshtari; Dorette Freyer; George Trendelenburg
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

6.  Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.

Authors:  Miguel Angel Merlos Rodrigo; Simona Dostalova; Hana Buchtelova; Vladislav Strmiska; Petr Michalek; Sona Krizkova; Ales Vicha; Pavla Jencova; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Vojtech Adam
Journal:  Oncotarget       Date:  2017-12-16

7.  Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.

Authors:  Yan-Fang Tao; Li-Xiao Xu; Jun Lu; Lan Cao; Zhi-Heng Li; Shao-Yan Hu; Na-Na Wang; Xiao-Juan Du; Li-Chao Sun; Wen-Li Zhao; Pei-Fang Xiao; Fang Fang; Yan-Hong Li; Gang Li; He Zhao; Yi-Ping Li; Yun-Yun Xu; Jian Ni; Jian Wang; Xing Feng; Jian Pan
Journal:  J Transl Med       Date:  2014-06-25       Impact factor: 5.531

8.  Focusing on the protective effects of metallothionein-I/II in cerebral ischemia.

Authors:  Abass Eidizadeh; George Trendelenburg
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

9.  Copper nanoparticle-induced ovarian injury, follicular atresia, apoptosis, and gene expression alterations in female rats.

Authors:  Jing Yang; Shifu Hu; Meng Rao; Lixia Hu; Hui Lei; Yanqing Wu; Yingying Wang; Dandan Ke; Wei Xia; Chang-Hong Zhu
Journal:  Int J Nanomedicine       Date:  2017-08-18

Review 10.  Zinc, Carnosine, and Neurodegenerative Diseases.

Authors:  Masahiro Kawahara; Ken-Ichiro Tanaka; Midori Kato-Negishi
Journal:  Nutrients       Date:  2018-01-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.